Top Biotechnology companies in Italy by Net Cash Used For Investing Activities
Italy
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 3.58 M
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
|
| 2 |
USD 175.50 K
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
| 3 |
USD -925.86 K
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
| 4 |
USD -1.15 M
|
Dec. 31, 2023 | USD 7.70 | 1.62% |
|
Italy |
|
| 5 |
USD -16.44 M
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
|
| 6 |
USD -32.12 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
|
| 7 |
USD -272.29 M
|
Dec. 31, 2023 | USD 41.35 | 1.53% |
|
Italy |
|
| 8 |
USD -419.00 M
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
Frequently Asked Questions
-
Which Biotechnology company in Italy has the highest Net Cash Used For Investing Activities ?
The Biotechnology company in Italy with the highest Net Cash Used For Investing Activities is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at USD 3.58 M.
-
Which Biotechnology company in Italy has the lowest Net Cash Used For Investing Activities ?
The Biotechnology company in Italy with the lowest Net Cash Used For Investing Activities is Recordati Industria Chimica e Farmaceutica S.p.A. (Milan Stock Exchange: REC.MI) at USD -419.00 M.
-
What are the top 10 Biotechnology companies in Italy by Net Cash Used For Investing Activities ?
The top 10 Biotechnology companies in Italy by Net Cash Used For Investing Activities are Newron Pharmaceuticals S.p.A., Philogen S.p.A., Arterra Bioscience, Franchetti S.p.A., Genenta Science S.p.A., DiaSorin S.p.A., SOL S.p.A. and Recordati Industria Chimica e Farmaceutica S.p.A..
-
What are the bottom 10 Biotechnology companies in Italy by Net Cash Used For Investing Activities ?
The bottom 10 Biotechnology companies in Italy by Net Cash Used For Investing Activities are Recordati Industria Chimica e Farmaceutica S.p.A., SOL S.p.A., DiaSorin S.p.A., Genenta Science S.p.A., Franchetti S.p.A., Arterra Bioscience, Philogen S.p.A. and Newron Pharmaceuticals S.p.A..
